Adaptive Biotechnologies' Series C Round

Adaptive Biotechnologies raised a round of funding on July 12, 2013.

Adaptive Biotechnologies, formerly Adaptive TCR, is a pioneer in immunosequencing diagnostics, with a focus in oncology. The Company leverages advances in next generation sequencing ("NGS") to profile…

Articles about Adaptive Biotechnologies' Series C Round: